During the past decade, Ospedale San Pietro Fatebenefratelli conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Pietro Fatebenefratelli" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored and "DePuy International" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Pietro Fatebenefratelli" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator, "Mediolanum Cardio Research" with 1 trials as a collaborator and "Niguarda Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Pietro Fatebenefratelli" are "Rheumatoid Arthritis" (3 trials), "Breast Cancer" (2 trials), "Heart Failure" (2 trials), "Avascular Necrosis" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Ospedale San Pietro Fatebenefratelli" in a lesser frequency.

Most popular intervention types in "Ospedale San Pietro Fatebenefratelli" are "Drug" (6 trials), "Device" (5 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DMARDs" (1 trials), "DePuy Proxima™ Hip" (1 trials), "Device Programming of the Boston Scientific Cardiac Resynchronization Therapy Defibrillator (CRT-D)" (1 trials), "Docetaxel" (1 trials) and "Erlotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Pietro Fatebenefratelli" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale San Pietro Fatebenefratelli". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ospedale San Pietro Fatebenefratelli, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Pietro Fatebenefratelli, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Ospedale San Pietro Fatebenefratelli has several departments that took part in Clinical trials: "Ospedale San Pietro Fatebenefratelli, U.O Complessa Di Cardiologia" - 2 trials